343 related articles for article (PubMed ID: 9880934)
1. [Leishmaniasis: principles of the immune response and function of nitric oxide].
Bogdan C
Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):409-14. PubMed ID: 9880934
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
5. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.
Hall LR; Titus RG
J Immunol; 1995 Oct; 155(7):3501-6. PubMed ID: 7561045
[TBL] [Abstract][Full Text] [Related]
6. [Leishmania-macrophage interactions: role of cytokines and molecules co-involved in killing].
Faliero SM; Marzio R; Panaro MA; Brandonisio O
Parassitologia; 1995 Apr; 37(1):5-15. PubMed ID: 8532367
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase.
Blos M; Schleicher U; Soares Rocha FJ; Meissner U; Röllinghoff M; Bogdan C
Eur J Immunol; 2003 May; 33(5):1224-34. PubMed ID: 12731047
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Leishmania parasites and host cells.
Brandonisio O; Panaro MA; Sisto M; Acquafredda A; Fumarola L; Leogrande D
Parassitologia; 2000 Dec; 42(3-4):183-90. PubMed ID: 11686076
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages.
Stefani MM; Müller I; Louis JA
Eur J Immunol; 1994 Mar; 24(3):746-52. PubMed ID: 7510243
[TBL] [Abstract][Full Text] [Related]
10. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
13. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
McMahon-Pratt D; Alexander J
Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
[TBL] [Abstract][Full Text] [Related]
14. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania.
Holzmuller P; Bras-Gonçalves R; Lemesre JL
Parasitology; 2006; 132 Suppl():S19-32. PubMed ID: 17018162
[TBL] [Abstract][Full Text] [Related]
16. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
17. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
18. The effector mechanism and vaccination against cutaneous leishmaniasis.
Liew FY
Behring Inst Mitt; 1991 Feb; (88):239-43. PubMed ID: 2049044
[TBL] [Abstract][Full Text] [Related]
19. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
Moll H
Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
[TBL] [Abstract][Full Text] [Related]
20. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
